Home › Companies › Materialise

Materialise

NASDAQ: MTLS

Belgian company built on 3D printing software (its Magics build-prep suite is an industry default) plus a large medical and anatomical printing business and a service bureau. The software licences are the sticky, higher-margin part.

Live chart and quote by TradingView. Data may be delayed.

Timeline

6 entries, oldest first
  1. 2021
    2021

    Revenue 205.5 million euros, net profit 13.1 million

    Source

  2. 2022
    2022

    Revenue up 13 percent to 232.0 million euros, net loss 2.2 million

    Source

  3. 2023
    2023

    Revenue up 10.4 percent to 256.1 million euros, net profit 6.7 million

    Source

  4. 2024
    Jan 2024

    Brigitte de Vet-Veithen becomes CEO

    She succeeded co-founder Fried Vancraen, chief executive for 33 years, who became chairman.

    Source

  5. 2025
    2025

    Revenue flat at 267.6 million euros as medical grows 15.4 percent

    Materialise Medical reached 134.2 million euros, half of group revenue, offset by lower manufacturing revenue.

    Source

  6. 2026
    Aug 2026

    Second-quarter revenue up 8.1 percent to 70.1 million euros

    Net profit was 3.3 million euros, and full-year revenue guidance of 273 to 283 million euros held despite the sale of its RapidFit and eyewear businesses.

    Source

Informational only, not investment advice. Timeline entries are compiled by hand from public sources and can lag real events. Figures come from company reports and news, not from us. Private companies rarely publish financials; where a figure is not disclosed we say so instead of estimating it.